<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="372715">
  <stage>Registered</stage>
  <submitdate>11/04/2017</submitdate>
  <approvaldate>12/05/2017</approvaldate>
  <actrnumber>ACTRN12617000687392</actrnumber>
  <trial_identification>
    <studytitle>The effect of local anesthetic infiltration to the nerves which lies on pectoral (chest) muscles  on postoperative ( after operation) analgesia and opioid ( narcotic analgesics) consumption in aesthetic breast surgery operation.</studytitle>
    <scientifictitle>The effect of pectoral nerve blocks on postoperative analgesia and opioid consumption in aesthetic breast surgery operation.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil Known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>postoperative pain following breast reconstruction surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>At the end of breast surgery operation anesthesiologists will perform pectoral nerve blocks patients in intervention group. After skin disinfection first anesthesiologists will give 20 ml %0.25 bupivacaine to fascia which lies between pectoralis minor and serratus anterior muscles between 3. and 4. ribs guided under  ultrasound view.  Then the same amount of bupivacaine will be given fascia which lies between pectoralis major and minor muscles. We will use appropriate needles for this intervention.It will take approximately 5 minutes.</interventions>
    <comparator>no treatment</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>postoperative pain score which assessed with visual analog scale ( VAS)</outcome>
      <timepoint>Postoperative 0,1,2,4,6,8,12 and  24. hours</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Amount of postoperative opioid consumption for analgesia. which assessed with medical records and Patient controlled analgesia records.</outcome>
      <timepoint>postoperative 0,1,2,4,6,8,12 and  24. hours</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1) Will undergo Aesthetic breast surgery operation
2)between 20-65 years old
3)American Society of Anesthesiologists (ASA) physical status I-II patients.</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>1)antiepileptic drug use
2)Known allergy to study drugs
3)Severe renal or hepatic disease
4)Psychiatric disorders
5) Routine use of opioids or NSAI drugs
6)Pregnancy or lactation 
7)Neurpathic disorders
8) Rejects study participation or using patient controlled analgesia device</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>15/05/2017</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate>30/04/2018</anticipatedenddate>
    <actualenddate />
    <samplesize>54</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>2/05/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Konya</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Baskent University</primarysponsorname>
    <primarysponsoraddress> Taskent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No:11 06490 Bahcelievler / ANKARA</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Baskent University </fundingname>
      <fundingaddress> Taskent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No:11 06490 Bahcelievler / ANKARA</fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Using opioids for postoperative analgesia is a standard modality. But opioid related side effects like nausea-vomiting, respiratory depression, urinary retention, Pruritus limits its use. Peripheral nerve and truncus block with local anesthetics can improve postoperative analgesia and reduce opioid requirement.
Our primary purpose in this study ; to investigate effect of pectoral nerve blocks on postoperative analgesia and total opioid consumption in aesthetic breast surgery 
operation..
We will take written informed consent for all patients before the procedure. We will record age, height, weight, American Society of Anesthesiologists (ASA) physical status of all patients.We will randomize patients into two group with computer program.In the operation room, we will routinely monitor electrocardiography, peripheric oxygen saturation and blood pressure.Standard anesthesia induction will perform for general anesthesia.
At the end of breast surgery operation we will perform pectoral nerve blocks patients in intervention group. After skin disinfection first we will give 20 cc %0.25 bupivacaine fascia which lies between pectoralis minor and serratus anterior muscles between 3. and 4. ribs guided under  ultrasound view.  Then the same amount of bupivacaine will be given fascia which lies between pectoralis major and minor muscles. We will use appropriate needles for this intervention.It will take approximately 5 minutes. Both group ( control and intervebntion group) will take same postoperative analgesics routinely.
Postoperative analgesia will provided with patient controlled analgesia (PCA) device which contains opioid drugs. Postoperative analgesia  will measure with visual analog scale for pain and opioid consumption with PCA datas postoperative 0,1,2,4,6,8,12 and  24. hours .
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Baskent University Clinical Research Ethical Committee</ethicname>
      <ethicaddress>Taskent Caddesi 77. Sokak No:11 06490 Bahcelievler Cankaya/ Ankara</ethicaddress>
      <ethicapprovaldate>13/01/2017</ethicapprovaldate>
      <hrec>KA 16/358</hrec>
      <ethicsubmitdate>12/12/2016</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>Huseyin Ulas Pinar</name>
      <address>Baskent University Konya Research Center Anesthesiology Department
Hocacihan mah. saray cad. no:1 Selcuklu /Konya 
Postal Code : 42080</address>
      <phone>+905055251992</phone>
      <fax>+903322570637</fax>
      <email>huseyinpinar2002@yahoo.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Huseyin Ulas Pinar</name>
      <address>Baskent University Konya Research Center Anesthesiology Department
hocacihan mah saray cad No: 1 Selcuklu/Konya
Postal Code : 42080</address>
      <phone>+905055251992</phone>
      <fax>+903322570637</fax>
      <email>huseyinpinar2002@yahoo.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Huseyin Ulas Pinar</name>
      <address>Baskent University Konya Research Center Anesthesiology Department
hocacihan mah saray cad No: 1 Selcuklu/Konya
Postal Code : 42080</address>
      <phone>+905055251992</phone>
      <fax>+903322570637</fax>
      <email>huseyinpinar2002@yahoo.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>